Current stock page

Catalysts

ABSI Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Nov 13, 2026

ABSIAbsci Corporation

Healthcare / Biotechnology

Relative Leader / Watch

Strong Relative Position

NeutralEdge 9/10
$8.45−$0.69 (−7.50%)

Latest quote

  • Momentum
    85
  • Value
    —
  • Quality
    26
  • Risk resilience
    30
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
—

No upcoming reporting date is available yet.

AIQ Catalyst
AIQ 53/100

Momentum 85/100 and sentiment — before the next covered event.

Recent coverage
4 articles

Updated Nov 15, 2026 · Sentiment 13.71%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 85/100AIQ Edge 9/10 Strong Relative Position
Beat rate
38%
3 of 8 reported periods
Average surprise
-8.8%
Across covered historical reports
Latest result
-0.6%
Nov 12, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 12, 2026—-$0.19-$0.19-0.6%$657.81K$304K
Aug 11, 2026—-$0.19-$0.18+5.8%$919.58K$300K
May 7, 2026—-$0.20-$0.19+5.0%$1.26M$215K
Mar 24, 2026—-$0.16-$0.23-43.8%$1.34M$650K
Nov 12, 2025—-$0.19-$0.20-5.3%$1.38M$378K
Aug 12, 2025—-$0.19-$0.24-26.3%$5.17M$593K
May 13, 2025—-$0.23-$0.21+8.7%$1.3M$1.18M
Mar 18, 2025—-$0.22-$0.25-13.6%$4.87M$665K

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
11
Buy
1
Hold
12-month analyst target
$14.50
+71.60% versus current price
Based on 12 analyst observations. Targets are estimates, not predictions.
Low target
$14.00
+65.68% vs latest price
Average target
$14.50
+71.60% vs latest price
High target
$15.00
+77.51% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event date—

Upcoming earnings date not available yet.

Sentiment score—

News pressure around the setup.

Momentum score85

Where event reaction would show up first.

AIQ score53/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
12
Average target
$14.50
Target upside
71.60%
Target range
$14.00 - $15.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
3
Neutral
0
Negative
1
gurufocus.com · Nov 12, 2026

Absci (ABSI) Prepares Key Clinical Data Release and Expands Commercial Leadership

On November 12, 2026, Absci Corp (NASDAQ: ABSI) announced upcoming interim data from its ABS-201 Phase I/IIa HEADLINE trial targeting pattern hair loss, expecte

rttnews.com · Nov 12, 2026

Absci Names Gerry Muhle Chief Commercial Officer, Shares Down In Pre-market

Thursday, Absci Corp. (ABSI), a clinical pharmaceutical company, appointed Gerry Muhle as Chief Commercial Officer to lead its commercial strategy and support the development and commercialization of ABS-201 and its broader drug pipeline.

zacks.com · Nov 12, 2026

Absci Corporation (ABSI) Reports Q3 Loss, Misses Revenue Estimates

ABSCI CORP (ABSI) delivered earnings and revenue surprises of -13.33% and -88.43%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

seekingalpha.com · Nov 11, 2026

Absci Corporation (ABSI) Presents at 3rd Annual Guggenheim Healthcare Innovation Conference Transcript

Absci Corporation (ABSI) 3rd Annual Guggenheim Healthcare Innovation Conference November 10, 2026 1:00 PM ESTCompany ParticipantsAlexander Khan - CVP of...

Open full news and sentiment

ABSI Catalysts FAQ

What are the next catalysts for ABSI stock?

ABSI's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move ABSI stock?

Upcoming events that could move ABSI include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could ABSI's next earnings report affect the stock?

ABSI's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive ABSI stock higher?

ABSI could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt ABSI stock?

ABSI could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.